25.51 USD
-0.06 (-0.23%)
25.51 USD
0 (0%)
PGNY gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. PGNY scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PGNY is growing strongly while it is still valued neutral. This is a good combination! These ratings could make PGNY a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
PGNY had positive earnings in the past year.
PGNY had a positive operating cash flow in the past year.
PGNY had positive earnings in each of the past 5 years.
In the past 5 years PGNY always reported a positive cash flow from operatings.
1.2 Ratios
PGNY has a Return On Assets of 7.11%. This is amongst the best in the industry. PGNY outperforms 88.24% of its industry peers.
The Return On Equity of PGNY (10.10%) is better than 71.57% of its industry peers.
The Return On Invested Capital of PGNY (11.24%) is better than 83.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PGNY is in line with the industry average of 9.61%.
The 3 year average ROIC (8.25%) for PGNY is below the current ROIC(11.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROIC | 11.24% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
PGNY has a better Profit Margin (4.46%) than 77.45% of its industry peers.
In the last couple of years the Profit Margin of PGNY has declined.
Looking at the Operating Margin, with a value of 6.77%, PGNY is in the better half of the industry, outperforming 69.61% of the companies in the same industry.
PGNY's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 22.94%, PGNY perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
PGNY's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PGNY is creating some value.
Compared to 1 year ago, PGNY has less shares outstanding
Compared to 5 years ago, PGNY has more shares outstanding
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
PGNY has an Altman-Z score of 8.52. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PGNY (8.52) is better than 93.14% of its industry peers.
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.52 |
ROIC/WACC1.27
WACC8.88%
2.3 Liquidity
A Current Ratio of 2.96 indicates that PGNY has no problem at all paying its short term obligations.
PGNY has a Current ratio of 2.96. This is amongst the best in the industry. PGNY outperforms 84.31% of its industry peers.
A Quick Ratio of 2.96 indicates that PGNY has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.96, PGNY belongs to the top of the industry, outperforming 84.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 |
3. Growth
3.1 Past
PGNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.62%, which is quite good.
Measured over the past years, PGNY shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.77% on average per year.
The Revenue has grown by 11.41% in the past year. This is quite good.
Measured over the past years, PGNY shows a very strong growth in Revenue. The Revenue has been growing by 38.42% on average per year.
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
3.2 Future
PGNY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.94% yearly.
PGNY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.83% yearly.
EPS Next Y38.33%
EPS Next 2Y37.34%
EPS Next 3Y31.32%
EPS Next 5Y32.94%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.53%
Revenue Next 5Y8.83%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 40.49, the valuation of PGNY can be described as expensive.
PGNY's Price/Earnings ratio is in line with the industry average.
PGNY is valuated expensively when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 23.73, which indicates a rather expensive current valuation of PGNY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PGNY is on the same level as its industry peers.
PGNY is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.03, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.49 | ||
| Fwd PE | 23.73 |
4.2 Price Multiples
PGNY's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, PGNY is valued cheaply inside the industry as 82.35% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.37 | ||
| EV/EBITDA | 18.19 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PGNY has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PGNY's earnings are expected to grow with 31.32% in the coming years.
PEG (NY)1.06
PEG (5Y)N/A
EPS Next 2Y37.34%
EPS Next 3Y31.32%
5. Dividend
5.1 Amount
PGNY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
25.51
-0.06 (-0.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.97%
Inst Owner Change7.39%
Ins Owners1.49%
Ins Owner Change0.8%
Market Cap2.20B
Revenue(TTM)1.27B
Net Income(TTM)56.57M
Analysts81.25
Price TargetN/A
Short Float %6.68%
Short Ratio3.12
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.43%
Min EPS beat(2)14.22%
Max EPS beat(2)14.63%
EPS beat(4)3
Avg EPS beat(4)8.02%
Min EPS beat(4)-11.77%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)7.07%
EPS beat(12)9
Avg EPS beat(12)35.08%
EPS beat(16)13
Avg EPS beat(16)94.29%
Revenue beat(2)2
Avg Revenue beat(2)2.31%
Min Revenue beat(2)1.96%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.96%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.43%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)-0.09%
PT rev (1m)1.38%
PT rev (3m)1.38%
EPS NQ rev (1m)0.87%
EPS NQ rev (3m)5.45%
EPS NY rev (1m)24.93%
EPS NY rev (3m)28.22%
Revenue NQ rev (1m)-0.37%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)1.4%
Revenue NY rev (3m)1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.49 | ||
| Fwd PE | 23.73 | ||
| P/S | 1.73 | ||
| P/FCF | 11.37 | ||
| P/OCF | 10.57 | ||
| P/B | 3.93 | ||
| P/tB | 4.12 | ||
| EV/EBITDA | 18.19 |
EPS(TTM)0.63
EY2.47%
EPS(NY)1.08
Fwd EY4.21%
FCF(TTM)2.24
FCFY8.8%
OCF(TTM)2.41
OCFY9.46%
SpS14.72
BVpS6.5
TBVpS6.19
PEG (NY)1.06
PEG (5Y)N/A
Graham Number9.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROCE | 14.68% | ||
| ROIC | 11.24% | ||
| ROICexc | 27.43% | ||
| ROICexgc | 30.82% | ||
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% | ||
| FCFM | 15.25% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexgc growth 3Y11.16%
ROICexgc growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score7
Asset Turnover1.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 330.21% | ||
| Cap/Sales | 1.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 230.54% | ||
| Profit Quality | 342.01% | ||
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 8.52 |
F-Score7
WACC8.88%
ROIC/WACC1.27
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y38.33%
EPS Next 2Y37.34%
EPS Next 3Y31.32%
EPS Next 5Y32.94%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.53%
Revenue Next 5Y8.83%
EBIT growth 1Y31.12%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year39.63%
EBIT Next 3Y20.17%
EBIT Next 5Y15.66%
FCF growth 1Y-2.78%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y2.69%
OCF growth 3Y90.18%
OCF growth 5YN/A
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
What is the valuation status for PGNY stock?
ChartMill assigns a valuation rating of 5 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What are the PE and PB ratios of PROGYNY INC (PGNY) stock?
The Price/Earnings (PE) ratio for PROGYNY INC (PGNY) is 40.49 and the Price/Book (PB) ratio is 3.93.
Can you provide the expected EPS growth for PGNY stock?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 38.33% in the next year.